Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes perinatals.
Vigod SN, Frey BN, Clark CT, Grigoriadis S, Barker LC, Brown HK, Charlebois J, Dennis CL, Fairbrother N, Green SM, Letourneau NL, Oberlander TF, Sharma V, Singla DR, Stewart DE, Tomasi P, Ellington BD, Fleury C, Tarasoff LA, Tomfohr-Madsen LM, Da Costa D, Beaulieu S, Brietzke E, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV, Samaan Z, Schaffer A, Taylor VH, Tourjman SV, Ameringen MV, Yatham LN, Van Lieshout RJ.
Can J Psychiatry. 2025 Jun;70(6):429-489. doi: 10.1177/07067437241303031. Epub 2025 Feb 12.
PMID:39936923
A Comprehensive Review on Postpartum Depression.
Suryawanshi O 4th, Pajai S.
Cureus. 2022 Dec 20;14(12):e32745. doi: 10.7759/cureus.32745. eCollection 2022 Dec.
PMID:36686097
Identification of depression and anxiety during pregnancy: A systematic review and meta-analysis of test accuracy.
Rondung E, Massoudi P, Nieminen K, Wickberg B, Peira N, Silverstein R, Moberg K, Lundqvist M, Grundberg Å, Hultcrantz M.
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J.
BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8.
PMID:31948424
Maple Syrup Urine Disease.
Strauss KA, Puffenberger EG, Carson VJ.
2006 Jan 30 [updated 2020 Apr 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301495
The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period: A Multivariate Bayesian Meta-Analysis.
Fawcett EJ, Fairbrother N, Cox ML, White IR, Fawcett JM.